ellipticine has been researched along with Abnormalities, Drug-Induced in 2 studies
ellipticine : A organic heterotetracyclic compound that is pyrido[4,3-b]carbazole carrying two methyl substituents at positions 5 and 11.
Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Both p-HPPH and m-HPPH were much less developmentally toxic than DPH." | 1.28 | Use of Frog Embryo Teratogenesis Assay-Xenopus and an exogenous metabolic activation system to evaluate the developmental toxicity of diphenylhydantoin. ( Bantle, JA; Fort, DJ, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fort, DJ | 2 |
| Rayburn, JR | 1 |
| Bantle, JA | 2 |
2 other studies available for ellipticine and Abnormalities, Drug-Induced
| Article | Year |
|---|---|
Evaluation of acetaminophen-induced developmental toxicity using FETAX.
Topics: Abnormalities, Drug-Induced; Acetaminophen; Animals; Biological Assay; Biotransformation; Carbon Mon | 1992 |
Use of Frog Embryo Teratogenesis Assay-Xenopus and an exogenous metabolic activation system to evaluate the developmental toxicity of diphenylhydantoin.
Topics: Abnormalities, Drug-Induced; Animals; Biotransformation; Cimetidine; Cyclohexanes; Cyclohexenes; Dos | 1990 |